Moberg Pharma AB (publ) operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Moberg Pharma AB (publ) with three other
pharmaceutical manufacturers in Europe:
Hofseth Biocare ASA
sales of 118.48 million Norwegian Kroner [US$15.11 million]
Venture Life Group plc
of the United Kingdom
(£16.05 million [US$22.51 million]
based in the United Kingdom
(£10.88 million [US$15.26 million]
Moberg Pharma AB (publ) reported sales of SEK 439.03 million (US$51.91 million)
December of 2017.
increase of 31.3%
versus 2016, when the company's sales were SEK 334.30 million.
Sales at Moberg Pharma AB (publ) have increased during each of the previous five years
(and since 2012, sales have increased a total of 290%).